Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Twitter Submits Responses To Letter From Staff Of SEC Concerning Twitter’s Preliminary Proxy Statement

– Reuters  
byBenzinga Newsdesk
September 14, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

– Reuters

 

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Intercept Pharma Stock Tumbles: FDA Panel Votes Against Intercept’s Fatty Liver Drug, Dashing Its Dreams To Enter NASH Space

By Vandana Singh
May 22, 8:46 AM
FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benefits of Intercept Pharmaceutical Inc's (NASDAQ: ICPT) Ocaliva 25 mg, also known as Obeticholic acid (OCA), don't outweigh the risks in nonalcoholic steatohepatitis (NASH) patient

ICPT